Enteral Plastics Safety Group

BSNA represents the following associate members of the Enteral Plastics Safety Group


Vision:

To be recognised as the definitive & trusted voice of the enteral plastics industry committed to improving patient safety and clinical outcomes

Mission:

  • To represent the enteral plastics industry
  • To ensure that all patients have optimal access to high quality enteral plastic devices through choice and innovation
  • To deliver education and awareness and best practice, including in relation to the environment and sustainability
  • To promote collaboration between industry, healthcare professionals, patient groups and their Associations
Abbott

Abbott

Website
Cardinal Health

Cardinal Health

Website
Enteral UK

Enteral UK

Website
Fresenius Kabi

Fresenius Kabi

Website
Nestlé Health Science

Nestlé Health Science

Website
Nutricia

Nutricia

Website
Vygon

Vygon

Website

Enteral Plastic Safety Group (EPSG) Statement: Liquidised Food

Due to increasing enquiries from patients and clinicians regarding blended food, the EPSG recommends that any patient/carer wishing to administer liquidised food via their enteral feeding device should only do so after an individualised enteral feeding risk assessment has been carried out by a healthcare professional, in line with their Trust or Clinical Commissioning Group (CCG) risk assessment policy. NICE guidelines recommend that wherever possible, pre-packaged, ready-to-use feeds should be used in preference to feeds requiring decanting, reconstitution or dilution.1

Some enteral feeding devices may be suitable for use of liquidised feeds, but only under the advice of a healthcare professional. The EPSG recommends that the device instructions for use (IFU) should always be referred to.

1. National Institute for Health and Care Excellence (NICE) CG139. 2017. Recommendation 1.3.2.1

*The EPSG (Enteral Plastic Safety Group) represents UK enteral feeding devices suppliers. The following companies are members of the EPSG: Abbott; Avanos; Cardinal Health; Enteral UK; Fresenius Kabi; Neomed; Nestle Health Science; Nutricia; Vygon.

Updated November 2019

The full statement can be downloaded here.